US Stock MarketDetailed Quotes

RNAC Cartesian Therapeutics

Watchlist

16.620
-0.320-1.89%

Close Nov 21 16:00 ET

16.620
0.0000.00%

Post 16:00 ET

422.40MMarket Cap-359P/E (TTM)

Cartesian Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

-94.09%387K

537.17%33.45M

-1.65%5.84M

-76.53%26M

-50.78%8.27M

-68.37%6.55M

-86.63%5.25M

-82.53%5.94M

30.21%110.78M

-43.90%16.8M

Operating revenue

-94.09%387K

537.17%33.45M

-1.65%5.84M

-76.53%26M

-50.78%8.27M

-68.37%6.55M

-86.63%5.25M

-82.53%5.94M

30.21%110.78M

-43.90%16.8M

Cost of revenue

Gross profit

Operating expense

-8.43%17.96M

-17.58%19.69M

-21.10%19.19M

16.81%112.42M

76.34%44.6M

-12.07%19.62M

-6.00%23.89M

4.71%24.32M

7.32%96.24M

-2.20%25.29M

Selling and administrative expenses

-0.79%6.56M

15.10%7.03M

65.94%9.45M

70.07%40.58M

250.52%22.17M

14.63%6.61M

-2.02%6.11M

2.85%5.7M

13.97%23.86M

14.13%6.32M

-General and administrative expense

-0.79%6.56M

15.10%7.03M

65.94%9.45M

70.07%40.58M

250.52%22.17M

14.63%6.61M

-2.02%6.11M

2.85%5.7M

13.97%23.86M

14.13%6.32M

Research and development costs

-12.32%11.4M

-28.80%12.66M

-47.71%9.74M

-0.74%71.84M

18.26%22.43M

-21.39%13M

-7.30%17.78M

5.29%18.62M

5.30%72.38M

-6.65%18.97M

Operating profit

-34.52%-17.58M

173.81%13.76M

27.38%-13.35M

-694.41%-86.42M

-327.64%-36.33M

-717.07%-13.07M

-234.47%-18.64M

-270.62%-18.38M

416.25%14.54M

-308.34%-8.5M

Net non-operating interest income expense

6.53%-2.83M

-58.73%-1.27M

-5.17%-752K

-14.29%-808K

-6.58%-3.03M

-13.50%-807K

Non-operating interest expense

--0

-6.53%2.83M

--0

58.73%1.27M

5.17%752K

14.29%808K

6.58%3.03M

13.50%807K

Other net income (expense)

-223.84%-6.61M

-99.01%79K

-1,657.32%-43.48M

-742.48%-149.46M

-1,175.44%-160.33M

191.79%5.34M

276.12%8M

-113.22%-2.47M

1,120.31%23.26M

65.46%14.91M

Gain on sale of security

62.15%8.24M

-134.97%-2.71M

-71.64%-4.68M

-674.94%-131.85M

-1,063.58%-141.96M

187.43%5.08M

270.73%7.76M

-114.71%-2.73M

1,099.26%22.93M

63.52%14.73M

Special income (charges)

---15.1M

--2.5M

---39.3M

---18.3M

--0

----

-Less：Restructuring and merger&acquisition

--15.1M

---2.5M

--39.3M

--18.3M

--0

----

Other non- operating income (expenses)

-1.19%250K

19.18%292K

99.22%508K

109.39%691K

-135.43%-62K

25,200.00%253K

--245K

65.58%255K

2,100.00%330K

--175K

Income before tax

-168.64%-24.18M

221.51%13.84M

-162.31%-56.82M

-786.54%-238.71M

-3,608.62%-196.66M

-9.59%-9M

-232.39%-11.39M

-175.28%-21.66M

457.68%34.77M

-54.71%5.61M

Income tax

-3,019.87%-19M

-103.81%-609K

-308.70%-288K

Net income

-168.64%-24.18M

221.51%13.84M

-162.31%-56.82M

-721.02%-219.71M

-3,114.73%-177.66M

-14.05%-9M

-232.39%-11.39M

-175.28%-21.66M

237.73%35.38M

-51.85%5.89M

Net income continuous Operations

-168.64%-24.18M

221.51%13.84M

-162.31%-56.82M

-721.02%-219.71M

-3,114.73%-177.66M

-14.05%-9M

-232.39%-11.39M

-175.28%-21.66M

237.73%35.38M

-51.85%5.89M

Minority interest income

Net income attributable to the parent company

-168.64%-24.18M

221.51%13.84M

-162.31%-56.82M

-721.02%-219.71M

-3,114.73%-177.66M

-14.05%-9M

-232.39%-11.39M

-175.28%-21.66M

237.73%35.38M

-51.85%5.89M

Preferred stock dividends

Other preferred stock dividends

4.21M

Net income attributable to common stockholders

-168.64%-24.18M

184.55%9.63M

-162.31%-56.82M

-721.02%-219.71M

-3,114.73%-177.66M

-14.05%-9M

-232.39%-11.39M

-175.28%-21.66M

237.73%35.38M

-51.85%5.89M

Basic earnings per share

-94.83%-3.39

126.01%0.58

-147.64%-10.5

-791.67%-49.8

-4,722.22%-41.6

-16.00%-1.74

-223.89%-2.23

-161.45%-4.24

209.09%7.2

-70.00%0.9

Diluted earnings per share

-94.83%-3.39

124.22%0.54

-147.64%-10.5

-1,760.00%-49.8

-2,673.33%-41.6

-16.00%-1.74

-223.89%-2.23

-276.67%-4.24

145.45%3

-266.67%-1.5

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	-94.09%387K	537.17%33.45M	-1.65%5.84M	-76.53%26M	-50.78%8.27M	-68.37%6.55M	-86.63%5.25M	-82.53%5.94M	30.21%110.78M	-43.90%16.8M
Operating revenue	-94.09%387K	537.17%33.45M	-1.65%5.84M	-76.53%26M	-50.78%8.27M	-68.37%6.55M	-86.63%5.25M	-82.53%5.94M	30.21%110.78M	-43.90%16.8M
Cost of revenue
Gross profit
Operating expense	-8.43%17.96M	-17.58%19.69M	-21.10%19.19M	16.81%112.42M	76.34%44.6M	-12.07%19.62M	-6.00%23.89M	4.71%24.32M	7.32%96.24M	-2.20%25.29M
Selling and administrative expenses	-0.79%6.56M	15.10%7.03M	65.94%9.45M	70.07%40.58M	250.52%22.17M	14.63%6.61M	-2.02%6.11M	2.85%5.7M	13.97%23.86M	14.13%6.32M
-General and administrative expense	-0.79%6.56M	15.10%7.03M	65.94%9.45M	70.07%40.58M	250.52%22.17M	14.63%6.61M	-2.02%6.11M	2.85%5.7M	13.97%23.86M	14.13%6.32M
Research and development costs	-12.32%11.4M	-28.80%12.66M	-47.71%9.74M	-0.74%71.84M	18.26%22.43M	-21.39%13M	-7.30%17.78M	5.29%18.62M	5.30%72.38M	-6.65%18.97M
Operating profit	-34.52%-17.58M	173.81%13.76M	27.38%-13.35M	-694.41%-86.42M	-327.64%-36.33M	-717.07%-13.07M	-234.47%-18.64M	-270.62%-18.38M	416.25%14.54M	-308.34%-8.5M
Net non-operating interest income expense	0	0	0	6.53%-2.83M	0	-58.73%-1.27M	-5.17%-752K	-14.29%-808K	-6.58%-3.03M	-13.50%-807K
Non-operating interest expense	--0	--0	--0	-6.53%2.83M	--0	58.73%1.27M	5.17%752K	14.29%808K	6.58%3.03M	13.50%807K
Other net income (expense)	-223.84%-6.61M	-99.01%79K	-1,657.32%-43.48M	-742.48%-149.46M	-1,175.44%-160.33M	191.79%5.34M	276.12%8M	-113.22%-2.47M	1,120.31%23.26M	65.46%14.91M
Gain on sale of security	62.15%8.24M	-134.97%-2.71M	-71.64%-4.68M	-674.94%-131.85M	-1,063.58%-141.96M	187.43%5.08M	270.73%7.76M	-114.71%-2.73M	1,099.26%22.93M	63.52%14.73M
Special income (charges)	---15.1M	--2.5M	---39.3M	---18.3M	---18.3M	--0	--0	--0	--0	----
-Less：Restructuring and merger&acquisition	--15.1M	---2.5M	--39.3M	--18.3M	--18.3M	--0	--0	--0	--0	----
Other non- operating income (expenses)	-1.19%250K	19.18%292K	99.22%508K	109.39%691K	-135.43%-62K	25,200.00%253K	--245K	65.58%255K	2,100.00%330K	--175K
Income before tax	-168.64%-24.18M	221.51%13.84M	-162.31%-56.82M	-786.54%-238.71M	-3,608.62%-196.66M	-9.59%-9M	-232.39%-11.39M	-175.28%-21.66M	457.68%34.77M	-54.71%5.61M
Income tax				-3,019.87%-19M					-103.81%-609K	-308.70%-288K
Net income	-168.64%-24.18M	221.51%13.84M	-162.31%-56.82M	-721.02%-219.71M	-3,114.73%-177.66M	-14.05%-9M	-232.39%-11.39M	-175.28%-21.66M	237.73%35.38M	-51.85%5.89M
Net income continuous Operations	-168.64%-24.18M	221.51%13.84M	-162.31%-56.82M	-721.02%-219.71M	-3,114.73%-177.66M	-14.05%-9M	-232.39%-11.39M	-175.28%-21.66M	237.73%35.38M	-51.85%5.89M
Minority interest income
Net income attributable to the parent company	-168.64%-24.18M	221.51%13.84M	-162.31%-56.82M	-721.02%-219.71M	-3,114.73%-177.66M	-14.05%-9M	-232.39%-11.39M	-175.28%-21.66M	237.73%35.38M	-51.85%5.89M
Preferred stock dividends
Other preferred stock dividends		4.21M					0
Net income attributable to common stockholders	-168.64%-24.18M	184.55%9.63M	-162.31%-56.82M	-721.02%-219.71M	-3,114.73%-177.66M	-14.05%-9M	-232.39%-11.39M	-175.28%-21.66M	237.73%35.38M	-51.85%5.89M
Basic earnings per share	-94.83%-3.39	126.01%0.58	-147.64%-10.5	-791.67%-49.8	-4,722.22%-41.6	-16.00%-1.74	-223.89%-2.23	-161.45%-4.24	209.09%7.2	-70.00%0.9
Diluted earnings per share	-94.83%-3.39	124.22%0.54	-147.64%-10.5	-1,760.00%-49.8	-2,673.33%-41.6	-16.00%-1.74	-223.89%-2.23	-276.67%-4.24	145.45%3	-266.67%-1.5
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data